New Phase III INBUILD® Data Reveals Promise of Quantitative CT in Treating Pulmonary Fibrosis #United_Kingdom #Oxford #Brainomix #Pulmonary_Fibrosis #Quantitative_CT

New Phase III INBUILD® Data Reveals Promise of Quantitative CT in Treating Pulmonary Fibrosis #United_Kingdom #Oxford #Brainomix #Pulmonary_Fibrosis #Quantitative_CT
Brainomix Joins the Elite Future Fifty Scale-Up Programme in the UK #Oxford #UK #AI_Medical_Imaging #Brainomix #Future_Fifty
An #AI-powered #imaging tool developed by #Brainomix has been used to enrich data from a phase 2a trial of #EndeavorBioMedicines' hedgehog pathway inhibitor #taladegib, in development for #idiopathicpulmonaryfibrosis (IPF).
Breakthrough in Lung Disease Treatment: Brainomix and Endeavor BioMedicines Showcase Promising Results #United_Kingdom #Oxford #Brainomix #IPF #Endeavor_BioMedicines